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2554ABSTRACT
Background. Cystic fibrosis is a congenital, progressive disease affecting many organs. It
frequently leads to severe respiratory failure, which can be treated by means of a double
lung transplantation. Single lung transplantation is justified only in certain cases.
Case report. This is a case report describing a 20-year-old female patient who became the
recipient of a single lung transplant as a result of cystic fibrosis. The transplant was
performed during cardiothoracic surgery, which included an intervention in the right
atrium. At the age of 14, the patient underwent left pneumonectomy. In addition, the
patient had a percutaneous endoscopic gastrostomy placed and a vascular port
implanted. During preoperative evaluation, she presented with clinical symptoms of
chronic respiratory failure. The patient was approved for lung transplantation at the age
of 16. After 2 years on the national lung transplant waiting list, in 2018, the patient
underwent right lung transplantation and removal of numerous thrombi in the right
atrium during 1 procedure. This surgery was accomplished with the use of
extracorporeal circulation, which is an extracorporeal membrane oxygenator combined
with cardiopulmonary bypass. The patient was discharged 3 weeks after the procedure in
good general condition. Presently, her pulmonary function is excellent and she presents
with normal respiratory capacity.
Conclusions. Patients with cystic fibrosis often require double lung transplantation.
Under normal circumstances, performing only a single lung transplantation would be
considered medical malpractice. However, in certain cases, a single lung transplant is a life-
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Tel: þ48667288893. E-mail: latos.magdalena93@gmail.comCYSTIC fibrosis (CF) frequently leads to severe respi-ratory failure, which can be treated by means of lung
transplantation (LT). Double lung transplantation (DLT)
remains the gold standard for patients with CF [1,2]. Such
treatment increases life expectancy and improves pulmo-
nary function as measured by spirometry and the 6-minute
walk test [3]. Single lung transplantation (SLT) is justified
only in certain cases, such as a history of pneumonectomy
years before possible LT. Because the only lung must be
replaced during the procedure, proper oxygenation is
maintained by devices like cardiopulmonary bypass (CPB)
or extracorporeal membrane oxygenation (ECMO). If such
support is needed, ECMO has been proved to be superior to
standard CPB [4]. However, the following case report0
rg/10.1016/j.transproceed.2020.03.018depicts an unusual patient case requiring resourcefulness
and skill in planning the procedure.
CASE PRESENTATION
This case report describes a 20-year-old patient who is the recipient
of an SLT as a result of end-stage pulmonary failure in course of
CF. Her medical history before and after the procedure is presented
in Fig 1. The patient was born in 1999 and was diagnosed with CF atª 2020 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig 1. Medical history of a patient with distinction between the pretransplant and post-transplant period.
Fig 2. Chest radiograph before lung transplantation.
LUNG TRANSPLANT CARDIAC SURGERY IN CYSTIC FIBROSIS 2555the age of 6 weeks, as it was revealed that she is a carrier of a double
F508del mutation on chromosome 7. During the course of her
underlying disease, the patient suffered from recurrent infections of
the respiratory tract. Up to the time of her LT, she was always
malnourished and underweight. At the age of 10, she became
colonized with Pseudomonas aeruginosa and methicillin-resistant
Staphylococcus aureus. At the age of 13, the patient was treated
with intravenous voriconazole due to invasive respiratory aspergil-
losis (Aspergillus fumigatus), which eventually caused significant
pulmonary cirrhosis followed by left-side pneumonectomy. Histo-
pathological examination of the removed lung confirmed the irre-
versible pulmonary cirrhosis. Her state was gradually deteriorating.
She required implantation of a vascular port and percutaneous
endoscopic gastrostomy in her early teens. As it was mentioned
previously, owing to malnutrition and fat-soluble vitamin deficiency
(mainly vitamin D), she developed scoliosis, as depicted on Fig 2.
Her medical history was also significant for diabetes mellitus and
nephrolithiasis. Before the patient was referred to the lung trans-
plant facility, her pulmonary disease was progressing and included
episodes of hemoptysis and frequent hospitalizations with intrave-
nous administration of antibiotics. The patient was referred for LT
approval at the age of 16. At the time of her preoperative evalua-
tion, she was oxygen dependent and presented with 15% of pre-
dicted forced expiratory volume in 1 second with severe pulmonary
obstruction with a 35% Tiffeneau-Pinelli index. During the
6-minute walk test, she experienced a significant decrease in oxygen
saturation from 92% to 65% and reached a distance of only 219 m.
Her psychological assessment presented her as a compliant candi-
date for such a procedure. At the age of 19, a matching donor was
reported and the patient was admitted to undergo single LT. At the
time of admission for LT, the patient underwent routine echocar-
diographic assessment. This examination revealed indirect features
of pulmonary hypertension, including right ventricular enlargement
with a systolic pressure of 44 mm Hg, hypokinesis of the free wall,
and mild tricuspid valve regurgitation. Additionally, a polymorphic
tumor in the right atrium was suspected. Further radiologic
diagnostics were performed including a chest computed tomogra-
phy, which confirmed the presence of a tumor (Fig 3A). This
examination presented left-sided displacement of the mediastinum,
remnants of the left pulmonary artery and pulmonary veins,
and properly developed pulmonary circulation on the other side
(Fig 3B). Her remaining lung had substantial bronchiectasis and
was filled with dense mucus. It was decided that cardiac surgery will
be followed by SLT. Such a procedure required a resourceful
approach to cardiopulmonary support, and 3 stages of the proced-
ure are depicted in Fig 4 (please pay attention to the placement of
the clamps while reading about the stages of the procedure).Combined ECMO and CPB were designed in such a way that the
CPB and ECMO units were connected via the same circuitry. Such
a connection allowed for swift switching between the 2 units when
required throughout the course of entire procedure.
Introduction of the venous cannula to the right atrium (RA)
through the right internal jugular vein was performed using the
Seldinger technique. This cannula was used to drain blood from the
RA to the ECMO circuit. With an incision parallel to inguinal
ligament, the common femoral artery and vein were visualized and
5-0 purse-string closure sutures were placed in the common femoral
artery and vein through which the arterial and venous cannula were
introduced, respectively. A femoral drainage cannula should always
be introduced into the RA (via the inferior vena cava) under
transesophageal echocardiography supervision for safety pre-
cautions. The internal layer of each cannula is coated with heparin,
which provides the ability to run the ECMO for more than 24 hours
without the need for intravenous heparin.
Both venous (superior and inferior) cannulas were connected
into 1 and then divided again into 2 lines with the use of a Y-shaped
connector: 1 line for the ECMO circuit and 1 line for the CPB unit.
An identical connection between the ECMO and CPB was per-
formed with respect to the arterial cannula (Fig 4). Opening the
Fig 3. (A) Panel depicts the chest computed tomography with 1 measured thrombus. (B) Panel shows the 3-dimentional model of the
patient’s pulmonary circulation before the procedure. A vascular port device is present.
2556 ANTONCZYK, URLIK, LATOS ET ALchest cavity (anterolateral thoracotomy in the fifth intercostal space
on the right side) and preparation of the superior and inferior vena
cava was the next step. The lung was dissected and cleaned of ad-
hesions. The hilum of the lung was revealed and dissected. The
pericardial sac was opened and holding sutures were placed on the
superior and inferior vena cava. An adequate amount of heparin
was administered to start CPB. The CPB unit and cardiotomy
suction were turned on (with previous clamping of the ECMO lines
[venous and arterial] past the Y-shaped connector). Holding sutures
around the vena cava superior and vena cava inferior were tight-
ened and the RA was opened.
Removal of the tumors from the RA was performed on a beating
heart. When the RA was opened 4 mace-shaped tumors, each 1.0 toFig 4. Stages of the operation. A fu3.0 cm in length, were revealed around ostium of the vena cava
inferior and coronary sinus. They were excised and sent for histo-
pathological examination. The RA was closed with 2 layers of 4-
0 Prolene (Ethicon Inc, Somerville, NJ, United States) suture.
The next step was switching from CPB to ECMO. CPB and
cardiotomy suction were stopped.
Lines to the CPB were clamped past the Y-shaped connector and
the ECMO lines were unclamped.
Three-quarters of the full dose of protamine sulfate was
administered and 200 seconds activated clotting time was set.
Excision of the patient’s lung and implantation of the donor’s lung
were performed using the standard approach. The final stage con-
sisted of the explantation of the ECMO circuit and the CPB unit.ll description is given in the text.
LUNG TRANSPLANT CARDIAC SURGERY IN CYSTIC FIBROSIS 2557After closing the thoracotomy incision and finishing the main
part of the procedure, both femoral cannulas (venous and arterial)
were removed. Hemostasis and layered closure of the groin were
performed. Removal of the venous cannula previously introduced
through the jugular vein was uneventful [1 skin suture was placed
using 4-0 Prolene (Ethicon Inc)]. The patient left the operating
room without extracorporeal cardiopulmonary support.
Histologic examination of the removed tumors revealed that 3 of
them were partially organized thrombi and the remaining fourth
was a fibrotic thrombus.
Outcome after 1 Year
The patient remains under the care of our facility. She has already
achieved 1-year survival with excellent spirometry results (47% of
predicted forced expiratory volume in 1 second, 52% of predicted
forced vital capacity, and proper Tiffeneau-Pinelli index of 77%).
She also managed to walk 601 m during the 6-minute walk test with
stable oxygen saturation of 97%. After the procedure, she gained
weight and now presents with normal nutritional status. Her general
condition improved and, as a result, she had her permanent venous
access device explanted 6 months after the procedure. The rest of
the posttransplant course is presented in Fig 1.
DISCUSSION
LT as a treatment for end-stage respiratory failure provides
the best long-term survival among patients with CF ac-
cording to data from the International Society for Heart and
Lung Transplantation Registry [5]. Even though DLT seems
to carry more benefits than SLT, this therapeutic option
among some patients with CF is off limits. There was no
technical possibility that our patient could have a DLT
procedure because she underwent left-side pneumonectomy
years prior to transplantation. Such treatment was reported
to improve the patient’s condition, as Liew et al reported in
the case of a 14-year-old boy who underwent right pneu-
monectomy as a result of chronic history of collapse and
consolidation of his entire right lung [6]. It was described
that computed tomography revealed mild bronchiectasis of
the left lung. After pneumonectomy, the patient regained
good functional status. However, certain patients after
pneumonectomy will not be eligible for DLT, as their pul-
monary reserves will be diminished. The available literature
reports cases of patients with CF who achieved satisfactory
pulmonary capacity as recipients of SLT. Shennib et al
reported a case of a recipient of DLT who underwent
pneumonectomy 10 days after transplantation due to
infarction of the left lung [7]. According to their case report,
the patient is functioning extremely well. A standard DLT
procedure allows the surgeon to explant the native lung first
while ventilation is being maintained in the remaining lung
on specific mechanical ventilation settings. In the case of
patients who have had previous pneumonectomy, this pro-
cedure is not an option. Instead, oxygenation must beprovided extracorporeally. A study published by Machuca
et al found that intraoperative ECMO is a superior car-
diopulmonary support [4]. However, our case required
switching between these 2 devices, as the patient required
ECMO during preparation of the pulmonary hilum followed
by CPB support in order to perform removal of the masses
from the RA. After successful completion of this part, blood
flow was provided by the ECMO circuit in order to finish the
LT. Cardiac operations concomitant with LT do not seem to
increase a risk of death as reported by Shigemura et al, who
noted several cases of patients who underwent tricuspid
valvuloplasty followed by LT [8]. Their oxygenation and
circulation support was provided by CPB during the valvu-
loplasty and implantation of the first lung. Switching from 1
method of cardiopulmonary support to another in the case
of our patient was carried out carefully by an experienced
team and provided an excellent outcome, as our patient is
presently alive and well.REFERENCES
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et al. Cystic fibrosis: from qualification to lung transplantation, a
single center experience. Ann Transplant 20195;24:185-190. https://
doi.org/10.12659/AOT.914328.
[4] Machuca TN, Collaud S, Mercier O, Cheung M,
Cunningham V, Kim SJ, et al. Outcomes of intraoperative extra-
corporeal membrane oxygenation versus cardiopulmonary bypass
for lung transplantation. J Thorac Cardiovasc Surg 2015;149:
1152e7. https://doi.org/10.1016/j.jtcvs.2014.11.039.
[5] Chambers DC, Cherikh WS, Harhay MO, Hayes D Jr,
Hsich E, Khush KK, et al. The International Thoracic Organ
Transplant Registry of the International Society for Heart and Lung
Transplantation: thirty-sixth adult lung and heartelung trans-
plantation Reportd2019; focus theme: donor and recipient size
match. J Heart Lung Transplant 2019;38:1042e55.
[6] Liew Z, Mallikarjuna S, Hasan A, Gould FK, Bunn S,
Thomas MF, et al. Successful outcome following pneumonectomy
in a teenage boy with cystic fibrosis: a case report. BMC Pulm Med
2017;17:17. https://doi.org/10.1186/s12890-016-0350-x.
[7] Shennib H, Massard G, Gauthier R, Colman N, Mulder D.
Single lung transplantation for cystic fibrosis: is it an option? Cystic
Fibrosis Transplant Study Group. J Heart Lung Transplant 1993;12:
288e93.
[8] Shigemura N, Sareyyupoglu B, Bhama J, Bonde P, Thacker J,
Bermudez C, et al. Combining tricuspid valve repair with double
lung transplantation in patients with severe pulmonary hyperten-
sion, tricuspid regurgitation, and right ventricular dysfunction.
Chest 2011;140:1033e9. https://doi.org/10.1378/chest.10-2929.
